<!doctype html><html lang=en-us><head><meta name=generator content="Hugo 0.138.0"><meta charset=utf-8><meta http-equiv=X-UA-Compatible content="IE=edge"><meta name=viewport content="width=device-width,initial-scale=1"><title>Pipeline </title><meta name=description content="ASAP direct-acting antiviral discovery programs and research outputs"><meta name=robots content="noindex"><meta name=author content="newpixcom"><meta property="og:url" content="https://asapdiscovery.org/pipeline/"><meta property="og:site_name" content="ASAP Discovery Consortium"><meta property="og:title" content="Pipeline"><meta property="og:description" content="ASAP direct-acting antiviral discovery programs and research outputs"><meta property="og:locale" content="en_us"><meta property="og:type" content="website"><div id=cookie-notice><span>We would like to use third party cookies and scripts to improve the
functionality of this website.</span>
<a id=cookie-notice-accept class="btn btn-primary btn-sm">Approve</a>
<a id=cookie-notice-deny class="btn btn-primary btn-sm">Deny</a>
<a href=/privacy class="btn btn-primary btn-sm">More info</a></div><script>function createCookie(e,t,n){var s,o="";n&&(s=new Date,s.setTime(s.getTime()+n*24*60*60*1e3),o="; expires="+s.toUTCString()),document.cookie=e+"="+t+o+"; path=/"}function readCookie(e){for(var t,s=e+"=",o=document.cookie.split(";"),n=0;n<o.length;n++){for(t=o[n];t.charAt(0)==" ";)t=t.substring(1,t.length);if(t.indexOf(s)==0)return t.substring(s.length,t.length)}return null}function eraseCookie(e){createCookie(e,"",-1)}if(readCookie("cookie-notice-option")=="true"){function loadScriptAsync(e,t){if(typeof t!="function")throw new Error("Not a valid callback for async script load");var n=document.createElement("script");n.onload=t,n.src=e,document.head.appendChild(n)}loadScriptAsync("https://www.googletagmanager.com/gtag/js?id=G-M3L857X90H",function(){window.dataLayer=window.dataLayer||[];function e(){dataLayer.push(arguments)}e("js",new Date),e("config","G-M3L857X90H",{anonymize_ip:!0})})}else readCookie("cookie-notice-option")!="false"&&(document.getElementById("cookie-notice").style.display="block");document.getElementById("cookie-notice-accept").addEventListener("click",function(){createCookie("cookie-notice-option","true",31),document.getElementById("cookie-notice").style.display="none",location.reload()}),document.getElementById("cookie-notice-deny").addEventListener("click",function(){createCookie("cookie-notice-option","false",31),document.getElementById("cookie-notice").style.display="none",location.reload()})</script><link rel=canonical href=https://asapdiscovery.org/pipeline/><link rel="shortcut icon" type=image/png href="data:image/png;base64,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"><link href=/css/font.css rel=stylesheet type=text/css><link href=/css/kube.css rel=stylesheet type=text/css><link href=/css/kube.legenda.css rel=stylesheet type=text/css><link href=/css/highlight.css rel=stylesheet type=text/css><link href=/css/master.css rel=stylesheet type=text/css><link href=/css/kube.demo.css rel=stylesheet type=text/css><link href=/css/custom.css rel=stylesheet type=text/css><script src=/js/jquery-2.1.4.min.js type=text/javascript></script><script type=text/javascript src=/js/tocbot.min.js></script><script src=https://kit.fontawesome.com/5812ece076.js crossorigin=anonymous></script></head><body class=page-kube><header><div class=show-sm><div id=nav-toggle-box><div id=nav-toggle-brand><a href=/>ASAP Discovery Consortium</a></div><a data-component=toggleme data-target=#top href=# id=nav-toggle><i class=kube-menu></i></a></div></div><div class=hide-sm id=top><div id=top-brand><a href=/ title=home>ASAP Discovery Consortium</a></div><nav id=top-nav-main><ul><li><a href=/pipeline/>Pipeline</a></li><li><a href=/outputs/>Outputs</a></li><li><a href=https://www.choderalab.org/news/2021/10/26/asap-avidd-proposal>Concept</a></li><li><a href=/members/>Members</a></li><li><a href=/sab/>SAB</a></li><li><a href=/faq/>FAQ</a></li><li><a href=/awards/>Awards</a></li><li><a href=/forum/>Open Science Forum</a></li><li><a href=https://postera.ai/moonshot/>COVID Moonshot</a></li><li><a href=/open-science/>Open Science</a></li></ul></nav><nav id=top-nav-extra><ul></ul></nav></div></header><main><div id=hero class=wrap><h1>Pipeline</h1><p>ASAP direct-acting antiviral discovery programs and research outputs</p><center><i>Click on any shaded box to view data and resources associated with that stage.</i></center></div><div id=main><div class=container><div class=row><div class=col-1></div><div class=col-11><div class=row><div class=col-4><h3>Discovery Program</h3></div><div class=col-8><a href=#clinically-unprecedented><img title="No approved drugs available" width=28 src=img/icons/clinically-unprecedented.png></a>
<a href=#novel-mechanism-of-action><img title="Novel mechanism of action" width=28 src=img/icons/novel-mechanism.png></a>
<a href=#broad-spectrum><img title="Broad spectrum antvirial" width=28 src=img/icons/broad-spectrum.png></a>
<a href=#funding-source><img title="Funding Source" width=28 src=img/icons/funding-source.png></a>
<a href=#targeting-opportunity><img title="Molecular Target" width=28 src=img/icons/molecular-target.png></a>
<a href=#targeting-opportunity><img title="Targeting Opportunity" width=28 src=img/icons/target.png></a>
<a href=#molecules><img title=Molecules width=28 src=img/icons/molecule.png></a>
<a href=#structures><img title=Structures width=28 src=img/icons/structure.png></a>
<a href=#publications><img title=Publications width=28 src=img/icons/papers.png></a>
<a href=#circulating-variants><img title="Circulating Variants" width=28 src=img/icons/DMS.png></a>
<a href=#target-product-profile><img title="Target Product Profile (TPP)" width=28 src=img/icons/TPP.png></a>
<a href=#target-enabling-package><img title="Target Enabling Package (TEP)" width=28 src=img/icons/structure.png></a>
<a href=#target-candidate-profile><img title="Target Candidate Profile (TCP)" width=28 src=img/icons/TCP.png></a>
<a href=#assay-cascade><img title="Assay cascade" width=28 src=img/icons/assay-cascade.png></a>
<a href=#hit-to-lead><img title="Hit-to-lead progression" width=28 src=img/icons/hit-to-lead.png></a>
<a href=#covalent-targeting><img title="Covalent targeting" width=28 src=img/icons/covalent-targeting.png></a>
<a href=#lead-optimization><img title="Lead optimization" width=28 src=img/icons/lead-optimization.png></a>
<a href=#preclinical-programs><img title="Preclinical (IND-enabling) studies" width=28 src=img/icons/preclinical.png></a>
<a href=#investigational-new-drugs><img title="Investigational New Drug (IND) approval" width=28 src=img/icons/ind.png></a>
<a href=#clinical-trials><img title="Clinical trials" width=28 src=img/icons/clinical-trials.png></a>
<a href=#new-drug-approval><img title="New Drug Approval (NDA)" width=28 src=img/icons/NDA.png></a></div></div></div></div><div class=row><div class=col-1 style=display:flex;align-items:center><a href=../outputs/viral-families/#coronaviridae><img width=80 src=img/viruses/coronaviridae.png></a></div><div class=col-11><div class=container><div class=row><div class=col-4 style=display:flex;align-items:center><b>SARS-CoV-2 Mpro protease</b></div><div class=col-8><img title="No approved drugs" width=28 src=img/status/clinically-unprecedented_not-started.png>
<img title="Novel mechanism of action" width=28 src=img/status/novel-mechanism_not-started.png>
<img title="Broad spectrum" width=28 src=img/status/broad-spectrum_not-started.png>
<a href=https://dndi.org/press-releases/2021/covid-moonshot-funded-by-wellcome-to-rapidly-develop-safe-globally-accessible-affordable-antiviral-pill/><img title="Funding source for SARS-CoV-2 Mpro protease" width=28 src=img/icons/wellcome-logo.png></a>
<a href><img title="Target for SARS-CoV-2 Mpro protease" width=28 src=img/targets/SARS-CoV-2%20Mpro.png></a>
<a href=/outputs/targeting-opportunities/#MOONSHOT-COV-MPRO><img title="Targeting opportunity for SARS-CoV-2 Mpro protease" width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/molecules/#MOONSHOT-COV-MPRO><img title=Molecules width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/structures/#MOONSHOT-COV-MPRO><img title=Structures width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/publications/><img title=Publications width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/circulating-variants/#MOONSHOT-COV-MPRO><img title="Analysis of circulating variants for SARS-CoV-2 Mpro protease" width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/target-product-profiles/#ASAP-TPP-SARS-CoV-2><img title="Target Product Profile (TPP) for SARS-CoV-2 Mpro protease" width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/target-enabling-packages/#MOONSHOT-COV-MPRO><img title="Target Enabling Package (TEP) for SARS-CoV-2 Mpro protease" width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/target-candidate-profiles/#MOONSHOT-COV-MPRO><img title="Target Candidate Profile (TCP) for SARS-CoV-2 Mpro protease" width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/assay-cascades/#MOONSHOT-COV-MPRO><img title="Assay cascade for SARS-CoV-2 Mpro protease" width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/molecules/#MOONSHOT-COV-MPRO><img title="Hit-to-lead for SARS-CoV-2 Mpro protease" width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/molecules/#MOONSHOT-COV-MPRO><img title="Covalent targeting for SARS-CoV-2 Mpro protease" width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/molecules/#MOONSHOT-COV-MPRO><img title="Lead optimization for SARS-CoV-2 Mpro protease" width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/preclinical/#MOONSHOT-COV-MPRO><img title="Preclinical (IND-enabling) studies for SARS-CoV-2 Mpro protease" width=28 src=img/status/coronaviridae_play.png></a>
<a href=/outputs/investigational-new-drugs/#MOONSHOT-COV-MPRO><img title="Investigational New Drug (IND) approval for SARS-CoV-2 Mpro protease" width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/clinical-trials/#MOONSHOT-COV-MPRO><img title="Clinical trial for SARS-CoV-2 Mpro protease" width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/new-drug-approvals/#MOONSHOT-COV-MPRO><img title="New Drug Approval (NDA) for SARS-CoV-2 Mpro protease" width=28 src=img/status/coronaviridae_not-started.png></a></div></div></div><div class=container><div class=row><div class=col-4 style=display:flex;align-items:center><b>MERS-CoV/SARS-CoV-2 Mpro protease</b></div><div class=col-8><img title="No approved drugs" width=28 src=img/status/clinically-unprecedented_completed.png>
<img title="Novel mechanism of action" width=28 src=img/status/novel-mechanism_not-started.png>
<img title="Broad spectrum" width=28 src=img/status/broad-spectrum_completed.png>
<a href=https://reporter.nih.gov/search/EpbjKrq7Kki8EBHx4eMWbw/project-details/10513865><img title="Funding source for MERS-CoV/SARS-CoV-2 Mpro protease" width=28 src=img/icons/niaid-logo.png></a>
<a href><img title="Target for MERS-CoV/SARS-CoV-2 Mpro protease" width=28 src=img/targets/SARS-CoV-2%20Mpro.png></a>
<a href=/outputs/targeting-opportunities/#ASAP-COV-MPRO><img title="Targeting opportunity for MERS-CoV/SARS-CoV-2 Mpro protease" width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/molecules/#ASAP-COV-MPRO><img title=Molecules width=28 src=img/status/coronaviridae_in-progress.png></a>
<a href=/outputs/structures/#ASAP-COV-MPRO><img title=Structures width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/publications/><img title=Publications width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/circulating-variants/#ASAP-COV-MPRO><img title="Analysis of circulating variants for MERS-CoV/SARS-CoV-2 Mpro protease" width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/target-product-profiles/#ASAP-TPP-MERS-CoV-SARS-CoV-2><img title="Target Product Profile (TPP) for MERS-CoV/SARS-CoV-2 Mpro protease" width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/target-enabling-packages/#ASAP-COV-MPRO><img title="Target Enabling Package (TEP) for MERS-CoV/SARS-CoV-2 Mpro protease" width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/target-candidate-profiles/#ASAP-COV-MPRO><img title="Target Candidate Profile (TCP) for MERS-CoV/SARS-CoV-2 Mpro protease" width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/assay-cascades/#ASAP-COV-MPRO><img title="Assay cascade for MERS-CoV/SARS-CoV-2 Mpro protease" width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/molecules/#ASAP-COV-MPRO><img title="Hit-to-lead for MERS-CoV/SARS-CoV-2 Mpro protease" width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/molecules/#ASAP-COV-MPRO><img title="Covalent targeting for MERS-CoV/SARS-CoV-2 Mpro protease" width=28 src=img/status/coronaviridae_in-progress.png></a>
<a href=/outputs/molecules/#ASAP-COV-MPRO><img title="Lead optimization for MERS-CoV/SARS-CoV-2 Mpro protease" width=28 src=img/status/coronaviridae_play.png></a>
<a href=/outputs/preclinical/#ASAP-COV-MPRO><img title="Preclinical (IND-enabling) studies for MERS-CoV/SARS-CoV-2 Mpro protease" width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/investigational-new-drugs/#ASAP-COV-MPRO><img title="Investigational New Drug (IND) approval for MERS-CoV/SARS-CoV-2 Mpro protease" width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/clinical-trials/#ASAP-COV-MPRO><img title="Clinical trial for MERS-CoV/SARS-CoV-2 Mpro protease" width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/new-drug-approvals/#ASAP-COV-MPRO><img title="New Drug Approval (NDA) for MERS-CoV/SARS-CoV-2 Mpro protease" width=28 src=img/status/coronaviridae_not-started.png></a></div></div></div><div class=container><div class=row><div class=col-4 style=display:flex;align-items:center><b>SARS-CoV-2 nsp3 Mac1 macrodomain</b></div><div class=col-8><img title="No approved drugs" width=28 src=img/status/clinically-unprecedented_not-started.png>
<img title="Novel mechanism of action" width=28 src=img/status/novel-mechanism_completed.png>
<img title="Broad spectrum" width=28 src=img/status/broad-spectrum_not-started.png>
<a href=https://reporter.nih.gov/search/EpbjKrq7Kki8EBHx4eMWbw/project-details/10513865><img title="Funding source for SARS-CoV-2 nsp3 Mac1 macrodomain" width=28 src=img/icons/niaid-logo.png></a>
<a href><img title="Target for SARS-CoV-2 nsp3 Mac1 macrodomain" width=28 src=img/targets/mac1.png></a>
<a href=/outputs/targeting-opportunities/#ASAP-SARS-COV-2-NSP3-MAC1><img title="Targeting opportunity for SARS-CoV-2 nsp3 Mac1 macrodomain" width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/molecules/#ASAP-SARS-COV-2-NSP3-MAC1><img title=Molecules width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/structures/#ASAP-SARS-COV-2-NSP3-MAC1><img title=Structures width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/publications/><img title=Publications width=28 src=img/status/coronaviridae_in-progress.png></a>
<a href=/outputs/circulating-variants/#ASAP-SARS-COV-2-NSP3-MAC1><img title="Analysis of circulating variants for SARS-CoV-2 nsp3 Mac1 macrodomain" width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/target-product-profiles/#ASAP-TPP-SARS-CoV-2><img title="Target Product Profile (TPP) for SARS-CoV-2 nsp3 Mac1 macrodomain" width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/target-enabling-packages/#ASAP-SARS-COV-2-NSP3-MAC1><img title="Target Enabling Package (TEP) for SARS-CoV-2 nsp3 Mac1 macrodomain" width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/target-candidate-profiles/#ASAP-SARS-COV-2-NSP3-MAC1><img title="Target Candidate Profile (TCP) for SARS-CoV-2 nsp3 Mac1 macrodomain" width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/assay-cascades/#ASAP-SARS-COV-2-NSP3-MAC1><img title="Assay cascade for SARS-CoV-2 nsp3 Mac1 macrodomain" width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/molecules/#ASAP-SARS-COV-2-NSP3-MAC1><img title="Hit-to-lead for SARS-CoV-2 nsp3 Mac1 macrodomain" width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/molecules/#ASAP-SARS-COV-2-NSP3-MAC1><img title="Covalent targeting for SARS-CoV-2 nsp3 Mac1 macrodomain" width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/molecules/#ASAP-SARS-COV-2-NSP3-MAC1><img title="Lead optimization for SARS-CoV-2 nsp3 Mac1 macrodomain" width=28 src=img/status/coronaviridae_paused.png></a>
<a href=/outputs/preclinical/#ASAP-SARS-COV-2-NSP3-MAC1><img title="Preclinical (IND-enabling) studies for SARS-CoV-2 nsp3 Mac1 macrodomain" width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/investigational-new-drugs/#ASAP-SARS-COV-2-NSP3-MAC1><img title="Investigational New Drug (IND) approval for SARS-CoV-2 nsp3 Mac1 macrodomain" width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/clinical-trials/#ASAP-SARS-COV-2-NSP3-MAC1><img title="Clinical trial for SARS-CoV-2 nsp3 Mac1 macrodomain" width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/new-drug-approvals/#ASAP-SARS-COV-2-NSP3-MAC1><img title="New Drug Approval (NDA) for SARS-CoV-2 nsp3 Mac1 macrodomain" width=28 src=img/status/coronaviridae_not-started.png></a></div></div></div><div class=container><div class=row><div class=col-4 style=display:flex;align-items:center><b>SARS-CoV-2 N protein nucleocapsid</b></div><div class=col-8><img title="No approved drugs" width=28 src=img/status/clinically-unprecedented_not-started.png>
<img title="Novel mechanism of action" width=28 src=img/status/novel-mechanism_completed.png>
<img title="Broad spectrum" width=28 src=img/status/broad-spectrum_not-started.png>
<a href=https://reporter.nih.gov/search/EpbjKrq7Kki8EBHx4eMWbw/project-details/10513865><img title="Funding source for SARS-CoV-2 N protein nucleocapsid" width=28 src=img/icons/niaid-logo.png></a>
<a href><img title="Target for SARS-CoV-2 N protein nucleocapsid" width=28 src=img/targets/nucleocapsid.png></a>
<a href=/outputs/targeting-opportunities/#ASAP-SARS-COV-2-NPROTEIN><img title="Targeting opportunity for SARS-CoV-2 N protein nucleocapsid" width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/molecules/#ASAP-SARS-COV-2-NPROTEIN><img title=Molecules width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/structures/#ASAP-SARS-COV-2-NPROTEIN><img title=Structures width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/publications/><img title=Publications width=28 src=img/status/coronaviridae_in-progress.png></a>
<a href=/outputs/circulating-variants/#ASAP-SARS-COV-2-NPROTEIN><img title="Analysis of circulating variants for SARS-CoV-2 N protein nucleocapsid" width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/target-product-profiles/#ASAP-TPP-SARS-CoV-2><img title="Target Product Profile (TPP) for SARS-CoV-2 N protein nucleocapsid" width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/target-enabling-packages/#ASAP-SARS-COV-2-NPROTEIN><img title="Target Enabling Package (TEP) for SARS-CoV-2 N protein nucleocapsid" width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/target-candidate-profiles/#ASAP-SARS-COV-2-NPROTEIN><img title="Target Candidate Profile (TCP) for SARS-CoV-2 N protein nucleocapsid" width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/assay-cascades/#ASAP-SARS-COV-2-NPROTEIN><img title="Assay cascade for SARS-CoV-2 N protein nucleocapsid" width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/molecules/#ASAP-SARS-COV-2-NPROTEIN><img title="Hit-to-lead for SARS-CoV-2 N protein nucleocapsid" width=28 src=img/status/coronaviridae_paused.png></a>
<a href=/outputs/molecules/#ASAP-SARS-COV-2-NPROTEIN><img title="Covalent targeting for SARS-CoV-2 N protein nucleocapsid" width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/molecules/#ASAP-SARS-COV-2-NPROTEIN><img title="Lead optimization for SARS-CoV-2 N protein nucleocapsid" width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/preclinical/#ASAP-SARS-COV-2-NPROTEIN><img title="Preclinical (IND-enabling) studies for SARS-CoV-2 N protein nucleocapsid" width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/investigational-new-drugs/#ASAP-SARS-COV-2-NPROTEIN><img title="Investigational New Drug (IND) approval for SARS-CoV-2 N protein nucleocapsid" width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/clinical-trials/#ASAP-SARS-COV-2-NPROTEIN><img title="Clinical trial for SARS-CoV-2 N protein nucleocapsid" width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/new-drug-approvals/#ASAP-SARS-COV-2-NPROTEIN><img title="New Drug Approval (NDA) for SARS-CoV-2 N protein nucleocapsid" width=28 src=img/status/coronaviridae_not-started.png></a></div></div></div><div class=container><div class=row><div class=col-4 style=display:flex;align-items:center><b>SARS-CoV-2 nsp13 helicase</b></div><div class=col-8><img title="No approved drugs" width=28 src=img/status/clinically-unprecedented_not-started.png>
<img title="Novel mechanism of action" width=28 src=img/status/novel-mechanism_completed.png>
<img title="Broad spectrum" width=28 src=img/status/broad-spectrum_not-started.png>
<a href=https://reporter.nih.gov/search/EpbjKrq7Kki8EBHx4eMWbw/project-details/10513865><img title="Funding source for SARS-CoV-2 nsp13 helicase" width=28 src=img/icons/niaid-logo.png></a>
<a href><img title="Target for SARS-CoV-2 nsp13 helicase" width=28 src=img/targets/nsp13.png></a>
<a href=/outputs/targeting-opportunities/#ASAP-SARS-COV-2-NS3-HELICASE><img title="Targeting opportunity for SARS-CoV-2 nsp13 helicase" width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/molecules/#ASAP-SARS-COV-2-NS3-HELICASE><img title=Molecules width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/structures/#ASAP-SARS-COV-2-NS3-HELICASE><img title=Structures width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/publications/><img title=Publications width=28 src=img/status/coronaviridae_in-progress.png></a>
<a href=/outputs/circulating-variants/#ASAP-SARS-COV-2-NS3-HELICASE><img title="Analysis of circulating variants for SARS-CoV-2 nsp13 helicase" width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/target-product-profiles/#ASAP-TPP-SARS-CoV-2><img title="Target Product Profile (TPP) for SARS-CoV-2 nsp13 helicase" width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/target-enabling-packages/#ASAP-SARS-COV-2-NS3-HELICASE><img title="Target Enabling Package (TEP) for SARS-CoV-2 nsp13 helicase" width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/target-candidate-profiles/#ASAP-SARS-COV-2-NS3-HELICASE><img title="Target Candidate Profile (TCP) for SARS-CoV-2 nsp13 helicase" width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/assay-cascades/#ASAP-SARS-COV-2-NS3-HELICASE><img title="Assay cascade for SARS-CoV-2 nsp13 helicase" width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/molecules/#ASAP-SARS-COV-2-NS3-HELICASE><img title="Hit-to-lead for SARS-CoV-2 nsp13 helicase" width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/molecules/#ASAP-SARS-COV-2-NS3-HELICASE><img title="Covalent targeting for SARS-CoV-2 nsp13 helicase" width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/molecules/#ASAP-SARS-COV-2-NS3-HELICASE><img title="Lead optimization for SARS-CoV-2 nsp13 helicase" width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/preclinical/#ASAP-SARS-COV-2-NS3-HELICASE><img title="Preclinical (IND-enabling) studies for SARS-CoV-2 nsp13 helicase" width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/investigational-new-drugs/#ASAP-SARS-COV-2-NS3-HELICASE><img title="Investigational New Drug (IND) approval for SARS-CoV-2 nsp13 helicase" width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/clinical-trials/#ASAP-SARS-COV-2-NS3-HELICASE><img title="Clinical trial for SARS-CoV-2 nsp13 helicase" width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/new-drug-approvals/#ASAP-SARS-COV-2-NS3-HELICASE><img title="New Drug Approval (NDA) for SARS-CoV-2 nsp13 helicase" width=28 src=img/status/coronaviridae_not-started.png></a></div></div></div><div class=container><div class=row><div class=col-4 style=display:flex;align-items:center><b>SARS-CoV-2 nsp15 endoribonuclease</b></div><div class=col-8><img title="No approved drugs" width=28 src=img/status/clinically-unprecedented_not-started.png>
<img title="Novel mechanism of action" width=28 src=img/status/novel-mechanism_completed.png>
<img title="Broad spectrum" width=28 src=img/status/broad-spectrum_not-started.png>
<a href=https://reporter.nih.gov/search/EpbjKrq7Kki8EBHx4eMWbw/project-details/10513865><img title="Funding source for SARS-CoV-2 nsp15 endoribonuclease" width=28 src=img/icons/niaid-logo.png></a>
<a href><img title="Target for SARS-CoV-2 nsp15 endoribonuclease" width=28 src=img/targets/coronavirus-endoribonuclease.png></a>
<a href=/outputs/targeting-opportunities/#ASAP-SARS-COV-2-ENDORIBONUCLEASE><img title="Targeting opportunity for SARS-CoV-2 nsp15 endoribonuclease" width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/molecules/#ASAP-SARS-COV-2-ENDORIBONUCLEASE><img title=Molecules width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/structures/#ASAP-SARS-COV-2-ENDORIBONUCLEASE><img title=Structures width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/publications/><img title=Publications width=28 src=img/status/coronaviridae_in-progress.png></a>
<a href=/outputs/circulating-variants/#ASAP-SARS-COV-2-ENDORIBONUCLEASE><img title="Analysis of circulating variants for SARS-CoV-2 nsp15 endoribonuclease" width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/target-product-profiles/#ASAP-TPP-SARS-CoV-2><img title="Target Product Profile (TPP) for SARS-CoV-2 nsp15 endoribonuclease" width=28 src=img/status/coronaviridae_completed.png></a>
<a href=/outputs/target-enabling-packages/#ASAP-SARS-COV-2-ENDORIBONUCLEASE><img title="Target Enabling Package (TEP) for SARS-CoV-2 nsp15 endoribonuclease" width=28 src=img/status/coronaviridae_play.png></a>
<a href=/outputs/target-candidate-profiles/#ASAP-SARS-COV-2-ENDORIBONUCLEASE><img title="Target Candidate Profile (TCP) for SARS-CoV-2 nsp15 endoribonuclease" width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/assay-cascades/#ASAP-SARS-COV-2-ENDORIBONUCLEASE><img title="Assay cascade for SARS-CoV-2 nsp15 endoribonuclease" width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/molecules/#ASAP-SARS-COV-2-ENDORIBONUCLEASE><img title="Hit-to-lead for SARS-CoV-2 nsp15 endoribonuclease" width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/molecules/#ASAP-SARS-COV-2-ENDORIBONUCLEASE><img title="Covalent targeting for SARS-CoV-2 nsp15 endoribonuclease" width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/molecules/#ASAP-SARS-COV-2-ENDORIBONUCLEASE><img title="Lead optimization for SARS-CoV-2 nsp15 endoribonuclease" width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/preclinical/#ASAP-SARS-COV-2-ENDORIBONUCLEASE><img title="Preclinical (IND-enabling) studies for SARS-CoV-2 nsp15 endoribonuclease" width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/investigational-new-drugs/#ASAP-SARS-COV-2-ENDORIBONUCLEASE><img title="Investigational New Drug (IND) approval for SARS-CoV-2 nsp15 endoribonuclease" width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/clinical-trials/#ASAP-SARS-COV-2-ENDORIBONUCLEASE><img title="Clinical trial for SARS-CoV-2 nsp15 endoribonuclease" width=28 src=img/status/coronaviridae_not-started.png></a>
<a href=/outputs/new-drug-approvals/#ASAP-SARS-COV-2-ENDORIBONUCLEASE><img title="New Drug Approval (NDA) for SARS-CoV-2 nsp15 endoribonuclease" width=28 src=img/status/coronaviridae_not-started.png></a></div></div></div></div>&nbsp
   </div><div class=row><div class=col-1 style=display:flex;align-items:center><a href=../outputs/viral-families/#flaviviridae><img width=80 src=img/viruses/flaviviridae.png></a></div><div class=col-11><div class=container><div class=row><div class=col-4 style=display:flex;align-items:center><b>DENV/ZIKV NS2B/3 protease</b></div><div class=col-8><img title="No approved drugs" width=28 src=img/status/clinically-unprecedented_completed.png>
<img title="Novel mechanism of action" width=28 src=img/status/novel-mechanism_completed.png>
<img title="Broad spectrum" width=28 src=img/status/broad-spectrum_completed.png>
<a href=https://reporter.nih.gov/search/EpbjKrq7Kki8EBHx4eMWbw/project-details/10513865><img title="Funding source for DENV/ZIKV NS2B/3 protease" width=28 src=img/icons/niaid-logo.png></a>
<a href><img title="Target for DENV/ZIKV NS2B/3 protease" width=28 src=img/targets/DENV-ns2b-ns3.png></a>
<a href=/outputs/targeting-opportunities/#ASAP-DENV-ZIKV-NS2B-NS3><img title="Targeting opportunity for DENV/ZIKV NS2B/3 protease" width=28 src=img/status/flaviviridae_completed.png></a>
<a href=/outputs/molecules/#ASAP-DENV-ZIKV-NS2B-NS3><img title=Molecules width=28 src=img/status/flaviviridae_in-progress.png></a>
<a href=/outputs/structures/#ASAP-DENV-ZIKV-NS2B-NS3><img title=Structures width=28 src=img/status/flaviviridae_completed.png></a>
<a href=/outputs/publications/><img title=Publications width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/circulating-variants/#ASAP-DENV-ZIKV-NS2B-NS3><img title="Analysis of circulating variants for DENV/ZIKV NS2B/3 protease" width=28 src=img/status/flaviviridae_completed.png></a>
<a href=/outputs/target-product-profiles/#ASAP-TPP-DENV><img title="Target Product Profile (TPP) for DENV/ZIKV NS2B/3 protease" width=28 src=img/status/flaviviridae_completed.png></a>
<a href=/outputs/target-enabling-packages/#ASAP-DENV-ZIKV-NS2B-NS3><img title="Target Enabling Package (TEP) for DENV/ZIKV NS2B/3 protease" width=28 src=img/status/flaviviridae_completed.png></a>
<a href=/outputs/target-candidate-profiles/#ASAP-DENV-ZIKV-NS2B-NS3><img title="Target Candidate Profile (TCP) for DENV/ZIKV NS2B/3 protease" width=28 src=img/status/flaviviridae_completed.png></a>
<a href=/outputs/assay-cascades/#ASAP-DENV-ZIKV-NS2B-NS3><img title="Assay cascade for DENV/ZIKV NS2B/3 protease" width=28 src=img/status/flaviviridae_in-progress.png></a>
<a href=/outputs/molecules/#ASAP-DENV-ZIKV-NS2B-NS3><img title="Hit-to-lead for DENV/ZIKV NS2B/3 protease" width=28 src=img/status/flaviviridae_play.png></a>
<a href=/outputs/molecules/#ASAP-DENV-ZIKV-NS2B-NS3><img title="Covalent targeting for DENV/ZIKV NS2B/3 protease" width=28 src=img/status/flaviviridae_in-progress.png></a>
<a href=/outputs/molecules/#ASAP-DENV-ZIKV-NS2B-NS3><img title="Lead optimization for DENV/ZIKV NS2B/3 protease" width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/preclinical/#ASAP-DENV-ZIKV-NS2B-NS3><img title="Preclinical (IND-enabling) studies for DENV/ZIKV NS2B/3 protease" width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/investigational-new-drugs/#ASAP-DENV-ZIKV-NS2B-NS3><img title="Investigational New Drug (IND) approval for DENV/ZIKV NS2B/3 protease" width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/clinical-trials/#ASAP-DENV-ZIKV-NS2B-NS3><img title="Clinical trial for DENV/ZIKV NS2B/3 protease" width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/new-drug-approvals/#ASAP-DENV-ZIKV-NS2B-NS3><img title="New Drug Approval (NDA) for DENV/ZIKV NS2B/3 protease" width=28 src=img/status/flaviviridae_not-started.png></a></div></div></div><div class=container><div class=row><div class=col-4 style=display:flex;align-items:center><b>DENV/ZIKV/WNV RdRp polymerase</b></div><div class=col-8><img title="No approved drugs" width=28 src=img/status/clinically-unprecedented_completed.png>
<img title="Novel mechanism of action" width=28 src=img/status/novel-mechanism_completed.png>
<img title="Broad spectrum" width=28 src=img/status/broad-spectrum_completed.png>
<a href=https://reporter.nih.gov/search/EpbjKrq7Kki8EBHx4eMWbw/project-details/10513865><img title="Funding source for DENV/ZIKV/WNV RdRp polymerase" width=28 src=img/icons/niaid-logo.png></a>
<a href><img title="Target for DENV/ZIKV/WNV RdRp polymerase" width=28 src=img/targets/zika_ns5b.png></a>
<a href=/outputs/targeting-opportunities/#ASAP-ZIKA-NS5-RDRP><img title="Targeting opportunity for DENV/ZIKV/WNV RdRp polymerase" width=28 src=img/status/flaviviridae_completed.png></a>
<a href=/outputs/molecules/#ASAP-ZIKA-NS5-RDRP><img title=Molecules width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/structures/#ASAP-ZIKA-NS5-RDRP><img title=Structures width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/publications/><img title=Publications width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/circulating-variants/#ASAP-ZIKA-NS5-RDRP><img title="Analysis of circulating variants for DENV/ZIKV/WNV RdRp polymerase" width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/target-product-profiles/#ASAP-TPP-ZIKA><img title="Target Product Profile (TPP) for DENV/ZIKV/WNV RdRp polymerase" width=28 src=img/status/flaviviridae_completed.png></a>
<a href=/outputs/target-enabling-packages/#ASAP-ZIKA-NS5-RDRP><img title="Target Enabling Package (TEP) for DENV/ZIKV/WNV RdRp polymerase" width=28 src=img/status/flaviviridae_play.png></a>
<a href=/outputs/target-candidate-profiles/#ASAP-ZIKA-NS5-RDRP><img title="Target Candidate Profile (TCP) for DENV/ZIKV/WNV RdRp polymerase" width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/assay-cascades/#ASAP-ZIKA-NS5-RDRP><img title="Assay cascade for DENV/ZIKV/WNV RdRp polymerase" width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/molecules/#ASAP-ZIKA-NS5-RDRP><img title="Hit-to-lead for DENV/ZIKV/WNV RdRp polymerase" width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/molecules/#ASAP-ZIKA-NS5-RDRP><img title="Covalent targeting for DENV/ZIKV/WNV RdRp polymerase" width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/molecules/#ASAP-ZIKA-NS5-RDRP><img title="Lead optimization for DENV/ZIKV/WNV RdRp polymerase" width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/preclinical/#ASAP-ZIKA-NS5-RDRP><img title="Preclinical (IND-enabling) studies for DENV/ZIKV/WNV RdRp polymerase" width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/investigational-new-drugs/#ASAP-ZIKA-NS5-RDRP><img title="Investigational New Drug (IND) approval for DENV/ZIKV/WNV RdRp polymerase" width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/clinical-trials/#ASAP-ZIKA-NS5-RDRP><img title="Clinical trial for DENV/ZIKV/WNV RdRp polymerase" width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/new-drug-approvals/#ASAP-ZIKA-NS5-RDRP><img title="New Drug Approval (NDA) for DENV/ZIKV/WNV RdRp polymerase" width=28 src=img/status/flaviviridae_not-started.png></a></div></div></div><div class=container><div class=row><div class=col-4 style=display:flex;align-items:center><b>DENV/ZIKV/WNV NS5 methyltransferase</b></div><div class=col-8><img title="No approved drugs" width=28 src=img/status/clinically-unprecedented_completed.png>
<img title="Novel mechanism of action" width=28 src=img/status/novel-mechanism_completed.png>
<img title="Broad spectrum" width=28 src=img/status/broad-spectrum_completed.png>
<a href=https://reporter.nih.gov/search/EpbjKrq7Kki8EBHx4eMWbw/project-details/10513865><img title="Funding source for DENV/ZIKV/WNV NS5 methyltransferase" width=28 src=img/icons/niaid-logo.png></a>
<a href><img title="Target for DENV/ZIKV/WNV NS5 methyltransferase" width=28 src=img/targets/zika_ns5b.png></a>
<a href=/outputs/targeting-opportunities/#ASAP-DENV-NS5-MT><img title="Targeting opportunity for DENV/ZIKV/WNV NS5 methyltransferase" width=28 src=img/status/flaviviridae_completed.png></a>
<a href=/outputs/molecules/#ASAP-DENV-NS5-MT><img title=Molecules width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/structures/#ASAP-DENV-NS5-MT><img title=Structures width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/publications/><img title=Publications width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/circulating-variants/#ASAP-DENV-NS5-MT><img title="Analysis of circulating variants for DENV/ZIKV/WNV NS5 methyltransferase" width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/target-product-profiles/#ASAP-TPP-ZIKA><img title="Target Product Profile (TPP) for DENV/ZIKV/WNV NS5 methyltransferase" width=28 src=img/status/flaviviridae_completed.png></a>
<a href=/outputs/target-enabling-packages/#ASAP-DENV-NS5-MT><img title="Target Enabling Package (TEP) for DENV/ZIKV/WNV NS5 methyltransferase" width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/target-candidate-profiles/#ASAP-DENV-NS5-MT><img title="Target Candidate Profile (TCP) for DENV/ZIKV/WNV NS5 methyltransferase" width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/assay-cascades/#ASAP-DENV-NS5-MT><img title="Assay cascade for DENV/ZIKV/WNV NS5 methyltransferase" width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/molecules/#ASAP-DENV-NS5-MT><img title="Hit-to-lead for DENV/ZIKV/WNV NS5 methyltransferase" width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/molecules/#ASAP-DENV-NS5-MT><img title="Covalent targeting for DENV/ZIKV/WNV NS5 methyltransferase" width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/molecules/#ASAP-DENV-NS5-MT><img title="Lead optimization for DENV/ZIKV/WNV NS5 methyltransferase" width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/preclinical/#ASAP-DENV-NS5-MT><img title="Preclinical (IND-enabling) studies for DENV/ZIKV/WNV NS5 methyltransferase" width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/investigational-new-drugs/#ASAP-DENV-NS5-MT><img title="Investigational New Drug (IND) approval for DENV/ZIKV/WNV NS5 methyltransferase" width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/clinical-trials/#ASAP-DENV-NS5-MT><img title="Clinical trial for DENV/ZIKV/WNV NS5 methyltransferase" width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/new-drug-approvals/#ASAP-DENV-NS5-MT><img title="New Drug Approval (NDA) for DENV/ZIKV/WNV NS5 methyltransferase" width=28 src=img/status/flaviviridae_not-started.png></a></div></div></div><div class=container><div class=row><div class=col-4 style=display:flex;align-items:center><b>DENV/ZIKV/WNV NS3 helicase</b></div><div class=col-8><img title="No approved drugs" width=28 src=img/status/clinically-unprecedented_completed.png>
<img title="Novel mechanism of action" width=28 src=img/status/novel-mechanism_completed.png>
<img title="Broad spectrum" width=28 src=img/status/broad-spectrum_completed.png>
<a href=https://reporter.nih.gov/search/EpbjKrq7Kki8EBHx4eMWbw/project-details/10513865><img title="Funding source for DENV/ZIKV/WNV NS3 helicase" width=28 src=img/icons/niaid-logo.png></a>
<a href><img title="Target for DENV/ZIKV/WNV NS3 helicase" width=28 src=img/targets/DENV-ns2b-ns3.png></a>
<a href=/outputs/targeting-opportunities/#ASAP-ZIKA-NS3-HELICASE><img title="Targeting opportunity for DENV/ZIKV/WNV NS3 helicase" width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/molecules/#ASAP-ZIKA-NS3-HELICASE><img title=Molecules width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/structures/#ASAP-ZIKA-NS3-HELICASE><img title=Structures width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/publications/><img title=Publications width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/circulating-variants/#ASAP-ZIKA-NS3-HELICASE><img title="Analysis of circulating variants for DENV/ZIKV/WNV NS3 helicase" width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/target-product-profiles/#ASAP-TPP-ZIKA><img title="Target Product Profile (TPP) for DENV/ZIKV/WNV NS3 helicase" width=28 src=img/status/flaviviridae_completed.png></a>
<a href=/outputs/target-enabling-packages/#ASAP-ZIKA-NS3-HELICASE><img title="Target Enabling Package (TEP) for DENV/ZIKV/WNV NS3 helicase" width=28 src=img/status/flaviviridae_play.png></a>
<a href=/outputs/target-candidate-profiles/#ASAP-ZIKA-NS3-HELICASE><img title="Target Candidate Profile (TCP) for DENV/ZIKV/WNV NS3 helicase" width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/assay-cascades/#ASAP-ZIKA-NS3-HELICASE><img title="Assay cascade for DENV/ZIKV/WNV NS3 helicase" width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/molecules/#ASAP-ZIKA-NS3-HELICASE><img title="Hit-to-lead for DENV/ZIKV/WNV NS3 helicase" width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/molecules/#ASAP-ZIKA-NS3-HELICASE><img title="Covalent targeting for DENV/ZIKV/WNV NS3 helicase" width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/molecules/#ASAP-ZIKA-NS3-HELICASE><img title="Lead optimization for DENV/ZIKV/WNV NS3 helicase" width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/preclinical/#ASAP-ZIKA-NS3-HELICASE><img title="Preclinical (IND-enabling) studies for DENV/ZIKV/WNV NS3 helicase" width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/investigational-new-drugs/#ASAP-ZIKA-NS3-HELICASE><img title="Investigational New Drug (IND) approval for DENV/ZIKV/WNV NS3 helicase" width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/clinical-trials/#ASAP-ZIKA-NS3-HELICASE><img title="Clinical trial for DENV/ZIKV/WNV NS3 helicase" width=28 src=img/status/flaviviridae_not-started.png></a>
<a href=/outputs/new-drug-approvals/#ASAP-ZIKA-NS3-HELICASE><img title="New Drug Approval (NDA) for DENV/ZIKV/WNV NS3 helicase" width=28 src=img/status/flaviviridae_not-started.png></a></div></div></div></div>&nbsp
   </div><div class=row><div class=col-1 style=display:flex;align-items:center><a href=../outputs/viral-families/#picornaviridae><img width=80 src=img/viruses/picornaviridae.png></a></div><div class=col-11><div class=container><div class=row><div class=col-4 style=display:flex;align-items:center><b>EV-D68/A71 3C protease</b></div><div class=col-8><img title="No approved drugs" width=28 src=img/status/clinically-unprecedented_completed.png>
<img title="Novel mechanism of action" width=28 src=img/status/novel-mechanism_completed.png>
<img title="Broad spectrum" width=28 src=img/status/broad-spectrum_completed.png>
<a href=https://reporter.nih.gov/search/EpbjKrq7Kki8EBHx4eMWbw/project-details/10513865><img title="Funding source for EV-D68/A71 3C protease" width=28 src=img/icons/niaid-logo.png></a>
<a href><img title="Target for EV-D68/A71 3C protease" width=28 src=img/targets/enterovirus-3C-protease.png></a>
<a href=/outputs/targeting-opportunities/#ASAP-EVD68-3CLPRO><img title="Targeting opportunity for EV-D68/A71 3C protease" width=28 src=img/status/picornaviridae_completed.png></a>
<a href=/outputs/molecules/#ASAP-EVD68-3CLPRO><img title=Molecules width=28 src=img/status/picornaviridae_in-progress.png></a>
<a href=/outputs/structures/#ASAP-EVD68-3CLPRO><img title=Structures width=28 src=img/status/picornaviridae_completed.png></a>
<a href=/outputs/publications/><img title=Publications width=28 src=img/status/picornaviridae_in-progress.png></a>
<a href=/outputs/circulating-variants/#ASAP-EVD68-3CLPRO><img title="Analysis of circulating variants for EV-D68/A71 3C protease" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/target-product-profiles/#ASAP-TPP-EVD68-PEDIATRIC><img title="Target Product Profile (TPP) for EV-D68/A71 3C protease" width=28 src=img/status/picornaviridae_completed.png></a>
<a href=/outputs/target-enabling-packages/#ASAP-EVD68-3CLPRO><img title="Target Enabling Package (TEP) for EV-D68/A71 3C protease" width=28 src=img/status/picornaviridae_completed.png></a>
<a href=/outputs/target-candidate-profiles/#ASAP-EVD68-3CLPRO><img title="Target Candidate Profile (TCP) for EV-D68/A71 3C protease" width=28 src=img/status/picornaviridae_completed.png></a>
<a href=/outputs/assay-cascades/#ASAP-EVD68-3CLPRO><img title="Assay cascade for EV-D68/A71 3C protease" width=28 src=img/status/picornaviridae_completed.png></a>
<a href=/outputs/molecules/#ASAP-EVD68-3CLPRO><img title="Hit-to-lead for EV-D68/A71 3C protease" width=28 src=img/status/picornaviridae_play.png></a>
<a href=/outputs/molecules/#ASAP-EVD68-3CLPRO><img title="Covalent targeting for EV-D68/A71 3C protease" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/molecules/#ASAP-EVD68-3CLPRO><img title="Lead optimization for EV-D68/A71 3C protease" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/preclinical/#ASAP-EVD68-3CLPRO><img title="Preclinical (IND-enabling) studies for EV-D68/A71 3C protease" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/investigational-new-drugs/#ASAP-EVD68-3CLPRO><img title="Investigational New Drug (IND) approval for EV-D68/A71 3C protease" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/clinical-trials/#ASAP-EVD68-3CLPRO><img title="Clinical trial for EV-D68/A71 3C protease" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/new-drug-approvals/#ASAP-EVD68-3CLPRO><img title="New Drug Approval (NDA) for EV-D68/A71 3C protease" width=28 src=img/status/picornaviridae_not-started.png></a></div></div></div><div class=container><div class=row><div class=col-4 style=display:flex;align-items:center><b>EV-D68/A71 capsid assembly</b></div><div class=col-8><img title="No approved drugs" width=28 src=img/status/clinically-unprecedented_completed.png>
<img title="Novel mechanism of action" width=28 src=img/status/novel-mechanism_completed.png>
<img title="Broad spectrum" width=28 src=img/status/broad-spectrum_completed.png>
<a href=https://reporter.nih.gov/search/EpbjKrq7Kki8EBHx4eMWbw/project-details/10513865><img title="Funding source for EV-D68/A71 capsid assembly" width=28 src=img/icons/niaid-logo.png></a>
<a href><img title="Target for EV-D68/A71 capsid assembly" width=28 src=img/targets/enterovirus-VP1-capsid.png></a>
<a href=/outputs/targeting-opportunities/#ASAP-EVD68-EVA71-VP1-CAPSID><img title="Targeting opportunity for EV-D68/A71 capsid assembly" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/molecules/#ASAP-EVD68-EVA71-VP1-CAPSID><img title=Molecules width=28 src=img/status/picornaviridae_in-progress.png></a>
<a href=/outputs/structures/#ASAP-EVD68-EVA71-VP1-CAPSID><img title=Structures width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/publications/><img title=Publications width=28 src=img/status/picornaviridae_in-progress.png></a>
<a href=/outputs/circulating-variants/#ASAP-EVD68-EVA71-VP1-CAPSID><img title="Analysis of circulating variants for EV-D68/A71 capsid assembly" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/target-product-profiles/#ASAP-TPP-EVD68-PEDIATRIC><img title="Target Product Profile (TPP) for EV-D68/A71 capsid assembly" width=28 src=img/status/picornaviridae_completed.png></a>
<a href=/outputs/target-enabling-packages/#ASAP-EVD68-EVA71-VP1-CAPSID><img title="Target Enabling Package (TEP) for EV-D68/A71 capsid assembly" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/target-candidate-profiles/#ASAP-EVD68-EVA71-VP1-CAPSID><img title="Target Candidate Profile (TCP) for EV-D68/A71 capsid assembly" width=28 src=img/status/picornaviridae_completed.png></a>
<a href=/outputs/assay-cascades/#ASAP-EVD68-EVA71-VP1-CAPSID><img title="Assay cascade for EV-D68/A71 capsid assembly" width=28 src=img/status/picornaviridae_in-progress.png></a>
<a href=/outputs/molecules/#ASAP-EVD68-EVA71-VP1-CAPSID><img title="Hit-to-lead for EV-D68/A71 capsid assembly" width=28 src=img/status/picornaviridae_play.png></a>
<a href=/outputs/molecules/#ASAP-EVD68-EVA71-VP1-CAPSID><img title="Covalent targeting for EV-D68/A71 capsid assembly" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/molecules/#ASAP-EVD68-EVA71-VP1-CAPSID><img title="Lead optimization for EV-D68/A71 capsid assembly" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/preclinical/#ASAP-EVD68-EVA71-VP1-CAPSID><img title="Preclinical (IND-enabling) studies for EV-D68/A71 capsid assembly" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/investigational-new-drugs/#ASAP-EVD68-EVA71-VP1-CAPSID><img title="Investigational New Drug (IND) approval for EV-D68/A71 capsid assembly" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/clinical-trials/#ASAP-EVD68-EVA71-VP1-CAPSID><img title="Clinical trial for EV-D68/A71 capsid assembly" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/new-drug-approvals/#ASAP-EVD68-EVA71-VP1-CAPSID><img title="New Drug Approval (NDA) for EV-D68/A71 capsid assembly" width=28 src=img/status/picornaviridae_not-started.png></a></div></div></div><div class=container><div class=row><div class=col-4 style=display:flex;align-items:center><b>EV-D68/A71 2A protease</b></div><div class=col-8><img title="No approved drugs" width=28 src=img/status/clinically-unprecedented_completed.png>
<img title="Novel mechanism of action" width=28 src=img/status/novel-mechanism_completed.png>
<img title="Broad spectrum" width=28 src=img/status/broad-spectrum_completed.png>
<a href=https://reporter.nih.gov/search/EpbjKrq7Kki8EBHx4eMWbw/project-details/10513865><img title="Funding source for EV-D68/A71 2A protease" width=28 src=img/icons/niaid-logo.png></a>
<a href><img title="Target for EV-D68/A71 2A protease" width=28 src=img/targets/enterovirus-2A-protease.png></a>
<a href=/outputs/targeting-opportunities/#ASAP-EVD68-2APRO><img title="Targeting opportunity for EV-D68/A71 2A protease" width=28 src=img/status/picornaviridae_completed.png></a>
<a href=/outputs/molecules/#ASAP-EVD68-2APRO><img title=Molecules width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/structures/#ASAP-EVD68-2APRO><img title=Structures width=28 src=img/status/picornaviridae_completed.png></a>
<a href=/outputs/publications/><img title=Publications width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/circulating-variants/#ASAP-EVD68-2APRO><img title="Analysis of circulating variants for EV-D68/A71 2A protease" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/target-product-profiles/#ASAP-TPP-EVD68-PEDIATRIC><img title="Target Product Profile (TPP) for EV-D68/A71 2A protease" width=28 src=img/status/picornaviridae_completed.png></a>
<a href=/outputs/target-enabling-packages/#ASAP-EVD68-2APRO><img title="Target Enabling Package (TEP) for EV-D68/A71 2A protease" width=28 src=img/status/picornaviridae_completed.png></a>
<a href=/outputs/target-candidate-profiles/#ASAP-EVD68-2APRO><img title="Target Candidate Profile (TCP) for EV-D68/A71 2A protease" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/assay-cascades/#ASAP-EVD68-2APRO><img title="Assay cascade for EV-D68/A71 2A protease" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/molecules/#ASAP-EVD68-2APRO><img title="Hit-to-lead for EV-D68/A71 2A protease" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/molecules/#ASAP-EVD68-2APRO><img title="Covalent targeting for EV-D68/A71 2A protease" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/molecules/#ASAP-EVD68-2APRO><img title="Lead optimization for EV-D68/A71 2A protease" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/preclinical/#ASAP-EVD68-2APRO><img title="Preclinical (IND-enabling) studies for EV-D68/A71 2A protease" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/investigational-new-drugs/#ASAP-EVD68-2APRO><img title="Investigational New Drug (IND) approval for EV-D68/A71 2A protease" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/clinical-trials/#ASAP-EVD68-2APRO><img title="Clinical trial for EV-D68/A71 2A protease" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/new-drug-approvals/#ASAP-EVD68-2APRO><img title="New Drug Approval (NDA) for EV-D68/A71 2A protease" width=28 src=img/status/picornaviridae_not-started.png></a></div></div></div><div class=container><div class=row><div class=col-4 style=display:flex;align-items:center><b>EV-D68/A71 2A protease (intramolecular)</b></div><div class=col-8><img title="No approved drugs" width=28 src=img/status/clinically-unprecedented_completed.png>
<img title="Novel mechanism of action" width=28 src=img/status/novel-mechanism_completed.png>
<img title="Broad spectrum" width=28 src=img/status/broad-spectrum_completed.png>
<a href=https://reporter.nih.gov/search/EpbjKrq7Kki8EBHx4eMWbw/project-details/10513865><img title="Funding source for EV-D68/A71 2A protease (intramolecular)" width=28 src=img/icons/niaid-logo.png></a>
<a href><img title="Target for EV-D68/A71 2A protease (intramolecular)" width=28 src=img/targets/enterovirus-2A-protease.png></a>
<a href=/outputs/targeting-opportunities/#ASAP-EVD68-2APRO-INTRAMOL><img title="Targeting opportunity for EV-D68/A71 2A protease (intramolecular)" width=28 src=img/status/picornaviridae_completed.png></a>
<a href=/outputs/molecules/#ASAP-EVD68-2APRO-INTRAMOL><img title=Molecules width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/structures/#ASAP-EVD68-2APRO-INTRAMOL><img title=Structures width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/publications/><img title=Publications width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/circulating-variants/#ASAP-EVD68-2APRO-INTRAMOL><img title="Analysis of circulating variants for EV-D68/A71 2A protease (intramolecular)" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/target-product-profiles/#ASAP-TPP-EVD68-PEDIATRIC><img title="Target Product Profile (TPP) for EV-D68/A71 2A protease (intramolecular)" width=28 src=img/status/picornaviridae_completed.png></a>
<a href=/outputs/target-enabling-packages/#ASAP-EVD68-2APRO-INTRAMOL><img title="Target Enabling Package (TEP) for EV-D68/A71 2A protease (intramolecular)" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/target-candidate-profiles/#ASAP-EVD68-2APRO-INTRAMOL><img title="Target Candidate Profile (TCP) for EV-D68/A71 2A protease (intramolecular)" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/assay-cascades/#ASAP-EVD68-2APRO-INTRAMOL><img title="Assay cascade for EV-D68/A71 2A protease (intramolecular)" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/molecules/#ASAP-EVD68-2APRO-INTRAMOL><img title="Hit-to-lead for EV-D68/A71 2A protease (intramolecular)" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/molecules/#ASAP-EVD68-2APRO-INTRAMOL><img title="Covalent targeting for EV-D68/A71 2A protease (intramolecular)" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/molecules/#ASAP-EVD68-2APRO-INTRAMOL><img title="Lead optimization for EV-D68/A71 2A protease (intramolecular)" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/preclinical/#ASAP-EVD68-2APRO-INTRAMOL><img title="Preclinical (IND-enabling) studies for EV-D68/A71 2A protease (intramolecular)" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/investigational-new-drugs/#ASAP-EVD68-2APRO-INTRAMOL><img title="Investigational New Drug (IND) approval for EV-D68/A71 2A protease (intramolecular)" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/clinical-trials/#ASAP-EVD68-2APRO-INTRAMOL><img title="Clinical trial for EV-D68/A71 2A protease (intramolecular)" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/new-drug-approvals/#ASAP-EVD68-2APRO-INTRAMOL><img title="New Drug Approval (NDA) for EV-D68/A71 2A protease (intramolecular)" width=28 src=img/status/picornaviridae_not-started.png></a></div></div></div><div class=container><div class=row><div class=col-4 style=display:flex;align-items:center><b>EV-D68/A71 3CD protease</b></div><div class=col-8><img title="No approved drugs" width=28 src=img/status/clinically-unprecedented_completed.png>
<img title="Novel mechanism of action" width=28 src=img/status/novel-mechanism_completed.png>
<img title="Broad spectrum" width=28 src=img/status/broad-spectrum_completed.png>
<a href=https://reporter.nih.gov/search/EpbjKrq7Kki8EBHx4eMWbw/project-details/10513865><img title="Funding source for EV-D68/A71 3CD protease" width=28 src=img/icons/niaid-logo.png></a>
<a href><img title="Target for EV-D68/A71 3CD protease" width=28 src=img/targets/enterovirus-3C-protease.png></a>
<a href=/outputs/targeting-opportunities/#ASAP-EVD68-3CDPRO><img title="Targeting opportunity for EV-D68/A71 3CD protease" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/molecules/#ASAP-EVD68-3CDPRO><img title=Molecules width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/structures/#ASAP-EVD68-3CDPRO><img title=Structures width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/publications/><img title=Publications width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/circulating-variants/#ASAP-EVD68-3CDPRO><img title="Analysis of circulating variants for EV-D68/A71 3CD protease" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/target-product-profiles/#ASAP-TPP-EVD68-PEDIATRIC><img title="Target Product Profile (TPP) for EV-D68/A71 3CD protease" width=28 src=img/status/picornaviridae_completed.png></a>
<a href=/outputs/target-enabling-packages/#ASAP-EVD68-3CDPRO><img title="Target Enabling Package (TEP) for EV-D68/A71 3CD protease" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/target-candidate-profiles/#ASAP-EVD68-3CDPRO><img title="Target Candidate Profile (TCP) for EV-D68/A71 3CD protease" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/assay-cascades/#ASAP-EVD68-3CDPRO><img title="Assay cascade for EV-D68/A71 3CD protease" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/molecules/#ASAP-EVD68-3CDPRO><img title="Hit-to-lead for EV-D68/A71 3CD protease" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/molecules/#ASAP-EVD68-3CDPRO><img title="Covalent targeting for EV-D68/A71 3CD protease" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/molecules/#ASAP-EVD68-3CDPRO><img title="Lead optimization for EV-D68/A71 3CD protease" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/preclinical/#ASAP-EVD68-3CDPRO><img title="Preclinical (IND-enabling) studies for EV-D68/A71 3CD protease" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/investigational-new-drugs/#ASAP-EVD68-3CDPRO><img title="Investigational New Drug (IND) approval for EV-D68/A71 3CD protease" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/clinical-trials/#ASAP-EVD68-3CDPRO><img title="Clinical trial for EV-D68/A71 3CD protease" width=28 src=img/status/picornaviridae_not-started.png></a>
<a href=/outputs/new-drug-approvals/#ASAP-EVD68-3CDPRO><img title="New Drug Approval (NDA) for EV-D68/A71 3CD protease" width=28 src=img/status/picornaviridae_not-started.png></a></div></div></div></div>&nbsp
   </div><br></div><br><hr><p>For data from the COVID Moonshot predecessor program, please see the <a href=https://doi.org/10.1101/2020.10.29.339317>preprint</a>, <a href=https://covid.postera.ai/covid/activity_data>COVID Moonshot data portal</a>, and <a href=https://fragalysis.diamond.ac.uk/viewer/react/preview/target/Mpro>Fragalysis X-ray structure hub</a>.</p><div class="message error" data-component=message>This page is still in development. Please report any issues to <a href=https://github.com/asapdiscovery/asapdiscovery.github.io/issues>our issue tracker</a>.</div><p><a id=asap-resources></a></p><h2 id=asap-resources>ASAP Resources
<a href=#asap-resources><svg width="16" height="16" fill="currentcolor" class="bi bi-link" viewBox="0 0 16 16"><path d="M6.354 5.5H4a3 3 0 000 6h3a3 3 0 002.83-4H9c-.086.0-.17.01-.25.031A2 2 0 017 10.5H4a2 2 0 110-4h1.535c.218-.376.495-.714.82-1z"/><path d="M9 5.5a3 3 0 00-2.83 4h1.098A2 2 0 019 6.5h3a2 2 0 110 4h-1.535a4.02 4.02.0 01-.82 1H12a3 3 0 100-6H9z"/></svg></a></h2><p>ASAP maintains several open community resources to help foster a global antiviral discovery pipeline:</p><ul><li>Mutational fitness scans from analysis of circulating variants: <a href=https://jbloomlab.github.io/SARS2-mut-fitness/>SARS-CoV-2</a></li><li>Wetlab protocols are hosted at the <a href=https://protocols.io/workspaces/asap-discovery>ASAP protocols.io page</a></li><li>ASAP talks and datasets at the <a href="https://zenodo.org/communities/asapdrugdiscovery/?page=1&amp;size=20">ASAP Zenodo Community</a></li><li>ASAP plasmid resources are available through the <a href=http://addgene.org/asap>ASAP AddGene page</a> under the permissive <a href=https://www.nature.com/articles/nbt.4263>OpenMTA</a> whenever possible</li><li>ASAP compounds are available through <a href=https://enamine.net/>Enamine</a> without the need for an MTA</li><li>Recorded talks on the <a href=https://www.youtube.com/channel/UCJDt-ivduVKzjnK9XmCSlmQ>ASAP YouTube</a> and <a href=https://www.youtube.com/@AViDD-OSF>Open Antivirals YouTube</a> channels</li><li>The <a href=http://openantivirals.org>Open Antiviral Discovery Forum</a> enables multiple AViDD Centers to rapidly share information and resources for antiviral drug discovery</li></ul><p><a id=research-outputs></a></p><h1 id=asap-research-outputs>ASAP Research Outputs
<a href=#asap-research-outputs><svg width="16" height="16" fill="currentcolor" class="bi bi-link" viewBox="0 0 16 16"><path d="M6.354 5.5H4a3 3 0 000 6h3a3 3 0 002.83-4H9c-.086.0-.17.01-.25.031A2 2 0 017 10.5H4a2 2 0 110-4h1.535c.218-.376.495-.714.82-1z"/><path d="M9 5.5a3 3 0 00-2.83 4h1.098A2 2 0 019 6.5h3a2 2 0 110 4h-1.535a4.02 4.02.0 01-.82 1H12a3 3 0 100-6H9z"/></svg></a></h1><p>ASAP is an <a href=https://www.choderalab.org/news/2021/10/26/asap-avidd-proposal>open science antiviral discovery center</a> that aims to make all research outputs openly available as rapidly as possible to build a global antiviral discovery pipeline.
Below, we give an overview of all classes of ASAP&rsquo;s research outputs:</p><p><a id=viral-family></a></p><h4 id=viral-family>Viral Family
<a href=#viral-family><svg width="16" height="16" fill="currentcolor" class="bi bi-link" viewBox="0 0 16 16"><path d="M6.354 5.5H4a3 3 0 000 6h3a3 3 0 002.83-4H9c-.086.0-.17.01-.25.031A2 2 0 017 10.5H4a2 2 0 110-4h1.535c.218-.376.495-.714.82-1z"/><path d="M9 5.5a3 3 0 00-2.83 4h1.098A2 2 0 019 6.5h3a2 2 0 110 4h-1.535a4.02 4.02.0 01-.82 1H12a3 3 0 100-6H9z"/></svg></a></h4><p>The <strong>viral family</strong> describes the family of viruses ASAP aims to develop antivirals against.
ASAP aims to discover direct-acting antivirals with broad antiviral activity within a viral family, but the difficulty of achieving this goal means that some of our program objectives are more narrowly focused on viral family members of greatest pandemic concern.</p><p><a href=/outputs/viral-families>🔎 View all ASAP viral families</a></p><p><a id=targeting-opportunity></a></p><h4 id=targeting-opportunity>Targeting Opportunity
<a href=#targeting-opportunity><svg width="16" height="16" fill="currentcolor" class="bi bi-link" viewBox="0 0 16 16"><path d="M6.354 5.5H4a3 3 0 000 6h3a3 3 0 002.83-4H9c-.086.0-.17.01-.25.031A2 2 0 017 10.5H4a2 2 0 110-4h1.535c.218-.376.495-.714.82-1z"/><path d="M9 5.5a3 3 0 00-2.83 4h1.098A2 2 0 019 6.5h3a2 2 0 110 4h-1.535a4.02 4.02.0 01-.82 1H12a3 3 0 100-6H9z"/></svg></a></h4><p>A <strong>Targeting Opportunity</strong> provides an overview of the opportunity for targeting new antivirals to a specific target protein and mode of action.
This overview summarizes relevant information for drug hunters, including the relevant domain and binding sites to target, notable chemical matter, rationale for antiviral effects, and other useful information in prosecuting a discovery compaign against the target.</p><p><a href=/outputs/targeting-opportunities>🔎 View all ASAP Targeting Opportunities</a></p><p><a id=molecules></a></p><h4 id=molecules>Molecules
<a href=#molecules><svg width="16" height="16" fill="currentcolor" class="bi bi-link" viewBox="0 0 16 16"><path d="M6.354 5.5H4a3 3 0 000 6h3a3 3 0 002.83-4H9c-.086.0-.17.01-.25.031A2 2 0 017 10.5H4a2 2 0 110-4h1.535c.218-.376.495-.714.82-1z"/><path d="M9 5.5a3 3 0 00-2.83 4h1.098A2 2 0 019 6.5h3a2 2 0 110 4h-1.535a4.02 4.02.0 01-.82 1H12a3 3 0 100-6H9z"/></svg></a></h4><p>ASAP is synthesizing and assaying new molecules against numerous antiviral targets, and posting these publicly as part of our open science mission.</p><p><a href=/outputs/molecules>🔎 View all ASAP molecules and assay data</a></p><p><a id=structures></a></p><h4 id=structures>Structures
<a href=#structures><svg width="16" height="16" fill="currentcolor" class="bi bi-link" viewBox="0 0 16 16"><path d="M6.354 5.5H4a3 3 0 000 6h3a3 3 0 002.83-4H9c-.086.0-.17.01-.25.031A2 2 0 017 10.5H4a2 2 0 110-4h1.535c.218-.376.495-.714.82-1z"/><path d="M9 5.5a3 3 0 00-2.83 4h1.098A2 2 0 019 6.5h3a2 2 0 110 4h-1.535a4.02 4.02.0 01-.82 1H12a3 3 0 100-6H9z"/></svg></a></h4><p><a href=https://www.diamond.ac.uk/>Diamond Light Source</a> is a full partner in ASAP, producing numerous X-ray structures of molecules bound to antiviral targets.</p><p><a href=/outputs/structures>🔎 View all ASAP Structures</a></p><p><a id=publications></a></p><h4 id=publications>Publications
<a href=#publications><svg width="16" height="16" fill="currentcolor" class="bi bi-link" viewBox="0 0 16 16"><path d="M6.354 5.5H4a3 3 0 000 6h3a3 3 0 002.83-4H9c-.086.0-.17.01-.25.031A2 2 0 017 10.5H4a2 2 0 110-4h1.535c.218-.376.495-.714.82-1z"/><path d="M9 5.5a3 3 0 00-2.83 4h1.098A2 2 0 019 6.5h3a2 2 0 110 4h-1.535a4.02 4.02.0 01-.82 1H12a3 3 0 100-6H9z"/></svg></a></h4><p>ASAP aims to publish preprints of all work to ensure our scientific advances are rapidly and openly available to all.</p><p><a href=/outputs/publications>🔎 View all ASAP Publications</a></p><p><a id=circulating-variants></a></p><h4 id=analysis-of-circulating-variants>Analysis of circulating variants
<a href=#analysis-of-circulating-variants><svg width="16" height="16" fill="currentcolor" class="bi bi-link" viewBox="0 0 16 16"><path d="M6.354 5.5H4a3 3 0 000 6h3a3 3 0 002.83-4H9c-.086.0-.17.01-.25.031A2 2 0 017 10.5H4a2 2 0 110-4h1.535c.218-.376.495-.714.82-1z"/><path d="M9 5.5a3 3 0 00-2.83 4h1.098A2 2 0 019 6.5h3a2 2 0 110 4h-1.535a4.02 4.02.0 01-.82 1H12a3 3 0 100-6H9z"/></svg></a></h4><p>ASAP uses the <strong>analysis of circulating variants</strong> of viruses such as SARS-CoV-2 to identify functionally tolerated mutations to inform resistance-robust inhibitor discovery.</p><p><a href=/outputs/circulating-variants>🔎 View all ASAP analysis of circulating variant data</a></p><p><a id=deep-mutational-scanning></a></p><h4 id=deep-mutational-scanning>Deep mutational scanning
<a href=#deep-mutational-scanning><svg width="16" height="16" fill="currentcolor" class="bi bi-link" viewBox="0 0 16 16"><path d="M6.354 5.5H4a3 3 0 000 6h3a3 3 0 002.83-4H9c-.086.0-.17.01-.25.031A2 2 0 017 10.5H4a2 2 0 110-4h1.535c.218-.376.495-.714.82-1z"/><path d="M9 5.5a3 3 0 00-2.83 4h1.098A2 2 0 019 6.5h3a2 2 0 110 4h-1.535a4.02 4.02.0 01-.82 1H12a3 3 0 100-6H9z"/></svg></a></h4><p><strong>Deep mutational scanning (DMS)</strong> data helps identify mutations in the target that are functionally tolerated and could lead to resistance should these mutations abrogate binding of antivirals.
ASAP is using multiple techniques to rapidly generate DMS data for all targets of interest in order to inform the discovery of resistance-robust direct-acting antivirals.</p><p><a href=/outputs/deep-mutational-scanning>🔎 View all ASAP deep mutational scanning data</a></p><p><a id=target-product-profile></a></p><h4 id=target-product-profile-tpp>Target Product Profile (TPP)
<a href=#target-product-profile-tpp><svg width="16" height="16" fill="currentcolor" class="bi bi-link" viewBox="0 0 16 16"><path d="M6.354 5.5H4a3 3 0 000 6h3a3 3 0 002.83-4H9c-.086.0-.17.01-.25.031A2 2 0 017 10.5H4a2 2 0 110-4h1.535c.218-.376.495-.714.82-1z"/><path d="M9 5.5a3 3 0 00-2.83 4h1.098A2 2 0 019 6.5h3a2 2 0 110 4h-1.535a4.02 4.02.0 01-.82 1H12a3 3 0 100-6H9z"/></svg></a></h4><p>A <strong><a href=https://www.who.int/observatories/global-observatory-on-health-research-and-development/analyses-and-syntheses/target-product-profile/who-target-product-profiles>Target Product Profile (TPP)</a></strong> describes the desired characteristics of a drug product aimed to treat a particular disease or set of diseases.
All ASAP TPPs are <em>draft TPPs</em> intended to help guide the development of target candidate profiles (TCPs) for antiviral discovery within the ASAP Discovery Consortium.
ASAP works with stakeholders around the globe (such as the <a href=https://www.who.int/observatories/global-observatory-on-health-research-and-development/analyses-and-syntheses/target-product-profile/who-target-product-profiles>World Health Organization</a>) to align TPPs to ensure they meet the needs of communities and fulfill our mission of global, equitable, and affordable access to antiviral therapies.</p><p><a href=/outputs/target-product-profiles>🔎 View all ASAP Target Product Profiles (TPPs)</a></p><p><a id=target-candidate-profile></a></p><h4 id=target-candidate-profile-tcp>Target Candidate Profile (TCP)
<a href=#target-candidate-profile-tcp><svg width="16" height="16" fill="currentcolor" class="bi bi-link" viewBox="0 0 16 16"><path d="M6.354 5.5H4a3 3 0 000 6h3a3 3 0 002.83-4H9c-.086.0-.17.01-.25.031A2 2 0 017 10.5H4a2 2 0 110-4h1.535c.218-.376.495-.714.82-1z"/><path d="M9 5.5a3 3 0 00-2.83 4h1.098A2 2 0 019 6.5h3a2 2 0 110 4h-1.535a4.02 4.02.0 01-.82 1H12a3 3 0 100-6H9z"/></svg></a></h4><p>A <a href=https://www.mmv.org/research-development/information-scientists/target-product-profiles-target-candidate-profiles>Target Candidate Profile (TCP)</a> describes the objectives an ASAP drug discovery program aims to achieve to produce a preclinical candidate.
Our TCPs are informed by the corresponding <a href=#target-product-profile>Target Product Profiles (TPPs)</a> for the corresponding disease.</p><p><a href=/outputs/target-candidate-profiles>🔎 View all ASAP Target Candidate Profiles (TCPs)</a></p><p><a id=assay-cascade></a></p><h4 id=assay-cascades>Assay cascades
<a href=#assay-cascades><svg width="16" height="16" fill="currentcolor" class="bi bi-link" viewBox="0 0 16 16"><path d="M6.354 5.5H4a3 3 0 000 6h3a3 3 0 002.83-4H9c-.086.0-.17.01-.25.031A2 2 0 017 10.5H4a2 2 0 110-4h1.535c.218-.376.495-.714.82-1z"/><path d="M9 5.5a3 3 0 00-2.83 4h1.098A2 2 0 019 6.5h3a2 2 0 110 4h-1.535a4.02 4.02.0 01-.82 1H12a3 3 0 100-6H9z"/></svg></a></h4><p>An <strong><a href=https://www.researchgate.net/figure/Drug-discovery-assay-cascade-Example-assay-cascade-for-drug-discovery-and-where-3D_fig2_348991791>assay cascade</a></strong> is a defined set of assays and progression criteria used by a drug discovery program to achieve its <a href=#target-candidate-profile>Target Candidate Profile (TCP)</a> goals in a time- and cost-effective manner.</p><p><a href=/outputs/assay-cascades>🔎 View all ASAP assay cascades</a></p><p><a id=target-enabling-package></a></p><h4 id=target-enabling-package-tep>Target Enabling Package (TEP)
<a href=#target-enabling-package-tep><svg width="16" height="16" fill="currentcolor" class="bi bi-link" viewBox="0 0 16 16"><path d="M6.354 5.5H4a3 3 0 000 6h3a3 3 0 002.83-4H9c-.086.0-.17.01-.25.031A2 2 0 017 10.5H4a2 2 0 110-4h1.535c.218-.376.495-.714.82-1z"/><path d="M9 5.5a3 3 0 00-2.83 4h1.098A2 2 0 019 6.5h3a2 2 0 110 4h-1.535a4.02 4.02.0 01-.82 1H12a3 3 0 100-6H9z"/></svg></a></h4><p>A <a href=https://www.thesgc.org/tep>Target Enabling Package (TEP)</a> is a complete data package needed to enable structure-based drug discovery against an antiviral target.
Pioneered by the <a href=https://www.thesgc.org/tep>Structural Genomics Consortium</a>, each TEP contains relevant protein constructs and plasmid resources for one or more viral family members, protein expression and purification protocols, crystallization conditions, structures from an <a href=https://www.diamond.ac.uk/Instruments/Mx/Fragment-Screening.html>X-ray fragment screen at the Diamond Light Source XChem facility</a>, small molecule hits, and biochemical assay protocols with at least one validated inhibitor with quantifiable activity.</p><p><a href=/outputs/target-enabling-packages>🔎 View all ASAP Target Enabling Packages (TEPs)</a></p><p><a id=hit-to-lead></a></p><h4 id=hit-to-lead-progression>Hit-to-Lead Progression
<a href=#hit-to-lead-progression><svg width="16" height="16" fill="currentcolor" class="bi bi-link" viewBox="0 0 16 16"><path d="M6.354 5.5H4a3 3 0 000 6h3a3 3 0 002.83-4H9c-.086.0-.17.01-.25.031A2 2 0 017 10.5H4a2 2 0 110-4h1.535c.218-.376.495-.714.82-1z"/><path d="M9 5.5a3 3 0 00-2.83 4h1.098A2 2 0 019 6.5h3a2 2 0 110 4h-1.535a4.02 4.02.0 01-.82 1H12a3 3 0 100-6H9z"/></svg></a></h4><p>ASAP aims to produce high-quality lead compounds for nine viral targets within five years.</p><p><a href=/outputs/molecules>🔎 View all ASAP molecules and assay data</a></p><p><a id=covalent-targeting></a></p><h4 id=covalent-targeting>Covalent Targeting
<a href=#covalent-targeting><svg width="16" height="16" fill="currentcolor" class="bi bi-link" viewBox="0 0 16 16"><path d="M6.354 5.5H4a3 3 0 000 6h3a3 3 0 002.83-4H9c-.086.0-.17.01-.25.031A2 2 0 017 10.5H4a2 2 0 110-4h1.535c.218-.376.495-.714.82-1z"/><path d="M9 5.5a3 3 0 00-2.83 4h1.098A2 2 0 019 6.5h3a2 2 0 110 4h-1.535a4.02 4.02.0 01-.82 1H12a3 3 0 100-6H9z"/></svg></a></h4><p>ASAP is exploring covalent targeting strategies for cysteine and serine proteases.</p><p><a href=/outputs/molecules>🔎 View all ASAP molecules and assay data</a></p><p><a id=lead-optimization></a></p><h4 id=lead-optimization>Lead Optimization
<a href=#lead-optimization><svg width="16" height="16" fill="currentcolor" class="bi bi-link" viewBox="0 0 16 16"><path d="M6.354 5.5H4a3 3 0 000 6h3a3 3 0 002.83-4H9c-.086.0-.17.01-.25.031A2 2 0 017 10.5H4a2 2 0 110-4h1.535c.218-.376.495-.714.82-1z"/><path d="M9 5.5a3 3 0 00-2.83 4h1.098A2 2 0 019 6.5h3a2 2 0 110 4h-1.535a4.02 4.02.0 01-.82 1H12a3 3 0 100-6H9z"/></svg></a></h4><p>ASAP aims to pursue five lead optimization programs within five years, producing at least three candidates for preclinical development</p><p><a href=/outputs/molecules>🔎 View all ASAP molecules and assay data</a></p><p><a id=preclinical-programs></a></p><h4 id=preclinical-programs>Preclinical programs
<a href=#preclinical-programs><svg width="16" height="16" fill="currentcolor" class="bi bi-link" viewBox="0 0 16 16"><path d="M6.354 5.5H4a3 3 0 000 6h3a3 3 0 002.83-4H9c-.086.0-.17.01-.25.031A2 2 0 017 10.5H4a2 2 0 110-4h1.535c.218-.376.495-.714.82-1z"/><path d="M9 5.5a3 3 0 00-2.83 4h1.098A2 2 0 019 6.5h3a2 2 0 110 4h-1.535a4.02 4.02.0 01-.82 1H12a3 3 0 100-6H9z"/></svg></a></h4><p>ASAP aims to prosecute three IND-enabling preclinical programs within five years.</p><p><a href=/outputs/preclinical-programs>🔎 View all ASAP preclinical programs</a></p><p><a id=investigational-new-drugs></a></p><h4 id=investigational-new-drug-ind-filings>Investigational New Drug (IND) filings
<a href=#investigational-new-drug-ind-filings><svg width="16" height="16" fill="currentcolor" class="bi bi-link" viewBox="0 0 16 16"><path d="M6.354 5.5H4a3 3 0 000 6h3a3 3 0 002.83-4H9c-.086.0-.17.01-.25.031A2 2 0 017 10.5H4a2 2 0 110-4h1.535c.218-.376.495-.714.82-1z"/><path d="M9 5.5a3 3 0 00-2.83 4h1.098A2 2 0 019 6.5h3a2 2 0 110 4h-1.535a4.02 4.02.0 01-.82 1H12a3 3 0 100-6H9z"/></svg></a></h4><p>ASAP aims to produce three IND filings within five years.</p><p><a href=/outputs/investigational-new-drugs>🔎 View all ASAP Investigational New Drugs (INDs)</a></p><p><a id=clinical-trials></a></p><h4 id=clinical-trials>Clinical trials
<a href=#clinical-trials><svg width="16" height="16" fill="currentcolor" class="bi bi-link" viewBox="0 0 16 16"><path d="M6.354 5.5H4a3 3 0 000 6h3a3 3 0 002.83-4H9c-.086.0-.17.01-.25.031A2 2 0 017 10.5H4a2 2 0 110-4h1.535c.218-.376.495-.714.82-1z"/><path d="M9 5.5a3 3 0 00-2.83 4h1.098A2 2 0 019 6.5h3a2 2 0 110 4h-1.535a4.02 4.02.0 01-.82 1H12a3 3 0 100-6H9z"/></svg></a></h4><p>ASAP collaborates with downstream translational partners to carry the clinical candidates it discovers into clinical trials.
Note that the <a href=https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-21-050.html>AViDD U19 grant</a> held by ASAP is not used to fund clinical trials.</p><p><a href=/outputs/clinical-trials>🔎 View all ASAP clinical trials</a></p><p><a id=new-drug-approval></a></p><h4 id=new-drug-approval-nda>New Drug Approval (NDA)
<a href=#new-drug-approval-nda><svg width="16" height="16" fill="currentcolor" class="bi bi-link" viewBox="0 0 16 16"><path d="M6.354 5.5H4a3 3 0 000 6h3a3 3 0 002.83-4H9c-.086.0-.17.01-.25.031A2 2 0 017 10.5H4a2 2 0 110-4h1.535c.218-.376.495-.714.82-1z"/><path d="M9 5.5a3 3 0 00-2.83 4h1.098A2 2 0 019 6.5h3a2 2 0 110 4h-1.535a4.02 4.02.0 01-.82 1H12a3 3 0 100-6H9z"/></svg></a></h4><p>ASAP aims to work with partners to seek New Drug Approvals (NDAs) and carry our antivirals to manufacture with the goal of globally accessible and affordable therapeutics.</p><p><a href=/outputs/new-drug-approvals>🔎 View all ASAP New Drug Approvals (NDAs)</a></p></div></main><footer><footer id=footer><nav><ul><li><span>ASAP Discovery</span></li><li><a href=https://www.choderalab.org/news/2021/10/26/asap-avidd-proposal>About Us</a></li><li><a href=http://twitter.com/asap_discovery>Twitter <i class="fa-brands fa-twitter"></i></a></li><li><a href=https://github.com/asapdiscovery/asapdiscovery.github.io/blob/ef39d2ca859fd53561b9e6da52db5e98e59de6e5/assets/images/icons/README.md>Image Credits</a></li><li><a href=mailto:maggie.jameson@choderalab.org>Contact Us</a></li></ul></nav></footer><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/KaTeX/0.7.1/katex.min.css integrity=sha384-wITovz90syo1dJWVh32uuETPVEtGigN07tkttEqPv+uR2SE/mbQcG7ATL28aI9H0 crossorigin=anonymous><script src=https://cdnjs.cloudflare.com/ajax/libs/KaTeX/0.7.1/katex.min.js integrity=sha384-/y1Nn9+QQAipbNQWU65krzJralCnuOasHncUFXGkdwntGeSvQicrYkiUBwsgUqc1 crossorigin=anonymous></script><script src=https://cdnjs.cloudflare.com/ajax/libs/KaTeX/0.7.1/contrib/auto-render.min.js integrity=sha384-dq1/gEHSxPZQ7DdrM82ID4YVol9BYyU7GbWlIwnwyPzotpoc57wDw/guX8EaYGPx crossorigin=anonymous></script><script>renderMathInElement(document.body,{delimiters:[{left:"$$",right:"$$",display:!0},{left:"$",right:"$",display:!1}]});for(var inlineMath,tex,replaced,displayMathArray,displayMath,inlineMathArray=document.querySelectorAll("script[type='math/tex']"),i=0;i<inlineMathArray.length;i++)inlineMath=inlineMathArray[i],tex=inlineMath.innerText||inlineMath.textContent,replaced=document.createElement("span"),replaced.innerHTML=katex.renderToString(tex,{displayMode:!1}),inlineMath.parentNode.replaceChild(replaced,inlineMath);for(displayMathArray=document.querySelectorAll("script[type='math/tex; mode=display']"),i=0;i<displayMathArray.length;i++)displayMath=displayMathArray[i],tex=displayMath.innerHTML,replaced=document.createElement("span"),replaced.innerHTML=katex.renderToString(tex.replace(/%.*/g,""),{displayMode:!0}),displayMath.parentNode.replaceChild(replaced,displayMath)</script><script>renderMathInElement(document.body)</script></footer><script src=/js/kube.js type=text/javascript></script><script src=/js/kube.legenda.js type=text/javascript></script><script src=/js/master.js type=text/javascript></script></body></html>